Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA microarray analysis of pancreatic malignancies.

Regine Brandt1, Robert Grützmann, Andrea Bauer

  • 1Department of Medicine II, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|November 24, 2004
PubMed
Summary

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. This review compares microarray data to identify novel molecular markers for earlier diagnosis and improved treatment of this pancreatic cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corneal tomography detection of elevated ectasia risk in atopic dermatitis patients with no prior ophthalmologic diagnosis.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia·2026
Same author

Do Prophylactic Antibiotics Decrease Risk of Infection in Closed Percutaneous Pinning of Pediatric Hand Fractures?

Journal of pediatric orthopedics·2026
Same author

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix <i>in vitro</i>.

Oncology letters·2026
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.

The World Allergy Organization journal·2026
Same author

Patch Test Results With Additions to the European Baseline Series, 2021/22-Joint European Results of the ESSCA<sup>A</sup> and the EBS<sup>B</sup> Working Groups of the ESCD, and the GEIDAC<sup>C</sup>.

Contact dermatitis·2026

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with a dismal prognosis.
  • Improved diagnostic markers and therapeutic targets are crucial for better patient outcomes.
  • Advances in genomic research offer new avenues for understanding PDAC complexity.

Purpose of the Study:

  • To systematically review and compare existing microarray studies in PDAC.
  • To validate findings across multiple published datasets.
  • To discuss the utility of DNA array technology in pancreatic cancer research.

Main Methods:

  • Comprehensive literature search for PDAC microarray studies.
  • Comparative analysis of gene expression data from published studies.

Related Experiment Videos

  • Discussion of DNA array and other high-throughput technologies.
  • Main Results:

    • Microarray analysis allows simultaneous measurement of thousands of genes.
    • Comparison of published data aids in validating potential molecular markers.
    • Identification of key gene expression patterns in PDAC.

    Conclusions:

    • DNA array technology is a powerful tool for dissecting the molecular landscape of PDAC.
    • Validated molecular markers could lead to earlier diagnosis and targeted therapies.
    • Further research is needed to translate these findings into clinical practice.